Subscribe

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

LATE-BREAKING RESEARCH: PRACTICE MANAGEMENT
Abstract #PM07

Operation Angel on the Line: Oncology Pharmacist and Pharmacy Students Piloting a New Oral Chemotherapy Telehealth Clinic During the COVID-19 Pandemic

JHOP - March 2021 Vol 11 Special Feature - HOPA Abstracts, Chemotherapy, COVID-19

Presenter: Diana Tamer, PharmD, BCOP, Clinical Assistant Professor, University of Missouri-Kansas City

Co-Authors: Jake Wodtke, Pharmacy Student, PharmD Candidate, University of Missouri-Kansas City; Samira Zantout, Pharmacy Student, PharmD Candidate, University of Missouri-Kansas City; Timothy Schieber, Pharmacy Student, PharmD Candidate, University of Missouri-Kansas City

Background: Oral oncolytic agents continue to be on the forefront of cancer treatment advances. Although more convenient to patients, these treatments place significant responsibilities on patients and clinicians alike, to adhere to potentially complex regimens and schedules, and to monitor and manage serious side effects.1-3 Currently, no standardized guidelines exist for the outpatient management of patients receiving oral oncolytic agents. There is a significant need for patient and clinician education, standardized workflow, and further support for monitoring, to improve patients’ quality of life and treatment outcomes. For that reason, a telehealth clinic was launched by a clinical oncology pharmacy faculty and pharmacy student trainees at a community cancer center at the University of Missouri-Kansas City.

Objective: To describe the development of an oral chemotherapy telehealth clinic and its interventions at a community cancer center.

Methods: This study is a retrospective chart review of adult patients with cancer who were enrolled in the oral chemotherapy clinic at the University of Missouri-Kansas City cancer center between July 1, 2020, and October 30, 2020. Inclusion criteria included adult patients (age ≥18 years) with cancer who received treatment from an oncologist and had complete clinical notes from the provided telehealth service.

Results: During the study period, 59 (66% female) patients were included. The patients’ average age was 62.5 years. The race makeup consisted of white (N = 54; 91.5%), Asian (N = 3; 5.1%), and black or African American (N = 2; 3.4%). The average time since initiation of oral oncolytic therapy was 12.8 months. The average of number of comorbid conditions was 3.1. The average of number of interventions per visit was 2.9. The team made 174 interventions: 5% referrals to a primary care provider, 2% referrals to physical therapy, 1% referrals to a pain specialist, 4% referrals to a specialist, 2% referrals to social work or counseling services, 5% initiation of prescription medication, 16% initiating nonpharmacist recommendations, 1% discontinuing medications, 8% managing treatment-related adverse events, 6% adherence education, 9% symptom/disease management, 28% medication-reconciliation error, 5% drug interaction, 5% scheduling laboratory tests per visit, and 3% for scheduling follow-up visit with the provider (oncologist). The average patient-reported adherence was 99.1%. The average time spent to complete the visit was 25.3 minutes.

Conclusion: This study describes the establishment of a new standardized workflow for an oral chemotherapy telehealth clinic, including the clinic and student training, as well as clinic logistics and the type of interventions performed. This initiative to improve and standardize the oral chemotherapy workflow can lead to improved patient care and outcomes, while also providing a no-cost critical training opportunity for pharmacy students. This model can serve as a guidance to community cancer centers wishing to launch a similar initiative with limited resources.

  1. DeCardenas R, Helfrich JS. Oral therapies and safety issues for oncology practices: patient support is key to delivering safe oral chemotherapy. Oncol Issues. 2010;25:40-42.
  2. Weingart SN, Brown E, Bach PB, et al. NCCN task force report: oral chemotherapy. J Natl Compr Canc Netw. 2008;6(suppl 3):S1-S14.
  3. Jin J, Sklar GE, Min Sen Oh V, Chuen Li S. Factors affecting therapeutic compliance: a review from the patient’s perspective. Ther Clin Risk Manag. 2008;4:269-286.
Related Items
Protecting Patients with Cancer During the COVID-19 Pandemic
Robert Mancini, PharmD, BCOP, FHOPA, Timothy G. Tyler, PharmD, FCSHP, FHOPA
JHOP - April 2022 Vol 12, No 2 published on April 26, 2022 in Editorial, COVID-19
HOP(A) Springs Eternal
Bryna Delman Ewachiw, PharmD, BCOP, Mark L. Zangardi, PharmD, BCOP
JHOP - March 2022 Vol 12 Special Feature published on March 22, 2022 in Editorial, HOPA Abstracts
A Pooled Safety Analysis of Loncastuximab Tesirine in Relapsed or Refractory DLBCL in the LOTIS Clinical Trial Program: Incidence, Onset, and Management of Myelosuppression
JHOP - March 2022 Vol 12 Special Feature published on March 22, 2022 in HOPA Abstracts, Lymphoma
Evaluation of Empiric Double Coverage with Tobramycin for Adult Patients with Febrile Neutropenia
JHOP - March 2022 Vol 12 Special Feature published on March 22, 2022 in HOPA Abstracts
Treatment Patterns, Real-World Outcomes, and Resource Use in Patients with Non–MSI-High or Mismatch Repair Proficient Advanced Endometrial Cancer
JHOP - March 2022 Vol 12 Special Feature published on March 22, 2022 in HOPA Abstracts, Gynecologic Cancers
Development and Implementation of a Pharmacist-Led Virtual Clinic Improve the Management of Patients with Metastatic Breast Cancer Receiving CDK4/6 Inhibitors
JHOP - March 2022 Vol 12 Special Feature published on March 22, 2022 in HOPA Abstracts, Breast Cancer
Impact of a Remote Oncology Clinical Pharmacist Program in 4 Community Oncology Practices
JHOP - March 2022 Vol 12 Special Feature published on March 22, 2022 in HOPA Abstracts
Impact of PGY2 Oncology Pharmacy Residents’ Learning Experiences During the COVID-19 Pandemic
JHOP - March 2022 Vol 12 Special Feature published on March 22, 2022 in HOPA Abstracts
Integrated Health-System Specialty Pharmacy Support in Reducing Financial Toxicity of Oral Oncolytic Therapy
JHOP - March 2022 Vol 12 Special Feature published on March 22, 2022 in HOPA Abstracts
Perceptions of PGY2 Oncology Programs on Financial Toxicity Education and Preparedness
JHOP - March 2022 Vol 12 Special Feature published on March 22, 2022 in HOPA Abstracts
Copyright © Green Hill Healthcare Communications, LLC. All rights reserved.